The role of TRIM-family proteins and other host cell factors in the restriction of SARS-CoV-2
The role of TRIM-family proteins and other host cell factors in the restriction of SARS-CoV-2
批准号:
458681345
负责人:
Professor Dr. Armin Ensser
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2021
资助国家:
德国
项目状态:
已结题
起止时间:
2020-12-31 至 2022-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We postulate that hitherto unidentified TRIM proteins play critical roles in restricting Betacoronavirus host susceptibility and lytic replication. Coronavirus infection is characterized by productive viral replication. Molecular insight into the factors that modulate the susceptibility to lytic replication is of fundamental importance, in particular also with respect to obvious gender-related differences. Although major progress has been made towards identifying the viral factors that regulate virus attachment and fusion, our knowledge of host intrinsic factors that modulate replication is still rudimentary. Tripartite motif (TRIM) proteins are increasingly recognized as important antiviral (and also proviral) factors that modulate the replication of a wide range of RNA viruses and DNA viruses. TRIM proteins can inhibit viral replication by either directly targeting viral components or modulating the innate immune responses that result in antiviral gene expression. The mechanism of antiviral restriction often relies in the TRIM E3 ligase functions, which target viral or host proteins for proteasomal degradation. As another example, TRIM19 (also known as promyelocytic leukaemia protein, PML) restricts multiple RNA viruses and DNA viruses, by organizing PML nuclear bodies, in particular also in response to interferons [reviewed in 5, 6]. We will 1) identify TRIM family proteins restricting SARS-CoV-2, and 2) start to delineate the mechanism of identified SARS-CoV-2-restricting TRIMs. Using a replicon-marker system, which was developed in our lab and 3) CRISPR knockout will point out directions for continued research projects. If our study identifies a role of a TRIM protein in intrinsic immunity and host cell interaction against Coronavirus infection, this may be targeted for therapeutic intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gammaherpesviral tegument proteins - crucial effectors of viral infection
-
批准号:392416179
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Professor Dr. Armin Ensser
-
依托单位:
Das Rhadinovirale Onkoprotein Tip in der T-Zell-Transformation
-
批准号:34159180
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2006
-
负责人:Professor Dr. Armin Ensser
-
依托单位:
国内基金
海外基金
登录
查看更多内容
TRIM69促进瘢痕疙瘩纤维化的调控机制研究
-
批准号:2026JJ70128
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖臻阳
-
依托单位:
人脐带间充质干细胞来源的外泌体TRIM67介导METTL14/PINK1通路促进线粒体自噬抑制骨关节炎发展中软骨细胞铁死亡过程的机理研究
-
批准号:2026JJ82195
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:阳曙东
-
依托单位:
基于 hUC-MSCs外泌体miR-455-5p/TRIM33/Smad轴调控子宫内膜自噬修复宫腔粘连的机制研究
-
批准号:JCZRLH202600971
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ETS1通过募集TRIM24调节PARP1/NAD+/SIRT1轴改善BPD的作用机制研究
-
批准号:2026JJ81634
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨敏
-
依托单位:
TRIM25通过泛素蛋白酶体途径负性调控BRD7/YB1信号轴促进乳腺癌恶性进展的机制研究
-
批准号:2026JJ81328
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:段玉梅
-
依托单位:
基于TRIM47 介导的 TRAF2 泛素化修饰调控 NF-κB 通路研究麦冬皂苷 C 减轻放射性肺损伤的作用机制
-
批准号:2026JJ81022
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:马凯文
-
依托单位:
TRIM27/sumo-YBX3在白皮杉醇抑制内异症侵袭种植中的机制研究
-
批准号:2026JJ81114
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:苏津平
-
依托单位:
INHBA通过TRIM21/SLC25A10上调琥珀酸诱导结直肠癌免疫治疗耐药的分子机制研究
-
批准号:2026JJ50311
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:袁霞
-
依托单位:
NUDT21介导TRIM35选择性多聚腺苷酸化调控肺腺癌恶性进展的机制研究
-
批准号:2026JJ82175
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨德松
-
依托单位:
TRIM21介导PKM2 K166位点泛素化在黑色素瘤免疫逃逸中的作用及机制研究
-
批准号:2026JJ60582
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱素锶
-
依托单位: